Discontinued — last reported Q3 '14
Merck & Co. Intangible Assets Gross (Excluding Goodwill) increased by 31.4% to $55.41B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Intangible Assets Gross (Excluding Goodwill) shows an upward trend with a 9.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests significant investment in R&D or strategic acquisitions of intellectual property, which may drive future revenue growth.
This represents the total acquisition cost of non-physical assets such as patents, trademarks, and licenses, excluding g...
A key metric for pharma and tech companies to compare the depth of their patent portfolios and intellectual property moats.
intangible_assets_gross_excluding_goodwill| Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|
| Value | $41.75B | $41.60B | $42.16B | $55.41B |
| QoQ Change | — | -0.3% | +1.3% | +31.4% |
| YoY Change | — | -0.3% | +1.3% | +31.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.